This resulted in swelling and an increase in solubility of the nanoparticle matrix, enabling the increased release of the entrapped IFN at the tumour microenvironment pH, while at the same time protecting the entrapped IFN from the more acidic environment, and providing controlled release. The gene discussed is IFNA1; the disease is neoplasm.